Scientists have discovered a way to make gene editing safer and more precise — and it's an advance that could help bolster ...

REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).

You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical ...

Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.

Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.

Clinical evidence from studies on atrial fibrillation (AF) and total knee arthroplasty (TKA) indicates that FXI is an appealing target that may upend the $15 billion thromboembolism market, which is ...

Have you ever looked into the face of evil? Today, we’re taking a horrifying journey into the depths of the worst of humanity ...

Magnesium is essential to Cas9’s function, but many studies on the protein are done in a solution with a magnesium ...

Ark Invest bought shares of Alibaba, Intellia Therapeutics, and Baidu on Monday. Alibaba and Baidu are surging Chinese ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.